Martin Shkreli and EpiPen: Pricing, Influence, and Public Reaction
pharma-pricing
Martin Shkreli became a symbol of drug pricing controversy amid EpiPen debates, though he did not own or directly set EpiPen prices. His company, Turing Pharmaceuticals, acquire...
Open article